Replay 2020


2020-11-17/18 - POLITICO's fifth Health Care Summit



Serge Bernasconi
chief executive officer, MedTech Europe
Antonella Cardone
director, European Cancer Patient Organization
Maurizio Cecconi
head of department of anesthesia and intensive care medecine, humanitas research hospital milan; president-elect of the european society of intensive care medicine
Sara Cerdas
Member of European Parliament
Penny Clarke
deputy secretary-general, European Federation of Public Service Unions (EPSU)
Emer Cooke
Executive Director of the European Medicines Agency (EMA)
Anthony Costello
professor of global health and sustainable development, University College London
Caroline Costongs
director, EuroHealthNet
Kasper Ernest
Secretary general, Affordable Medicines Europe
Tim Garnett
chief medical officer and senior vice president, Lilly
Monique Goyens
Director general, The European Consumer Organisation
Marcus Guardian
Chief operating officer, EUnetHTA
Lena Hallengren
minister for health and social affairs, Sweden
Petr Horák
President, European Association of Hospital Pharmacists (EAHP)
Kaisa Immonen
director of policy, European Patients' Forum
Heidi J. Larson
professor of Anthropology, Risk and Decision Science, London School of Hygiene & Tropical Medicine and director, Vaccine Confidence Project
Peter Liese
Member of European Parliament
Nathalie Moll
director general, European Federation of Pharmaceutical Industries and Associations
Frank Ulrich Montgomery
President, Standing Committee of European Doctors (CPME)
David Nabarro
co-director of the Imperial College Institute of Global Health Innovation and special envoy on COVID-19 to the director general, Word Health Organization
Ben Newton
head of oncology solutions, GE Healthcare
Maria Teresa Parisotto
Executive Director of European Specialist Nurses Organisation. Brussels, Belgium
Thomas Renner
head of directorate “Digitalization and Innovation”, Ministry of Health, Germany
Walter Ricciardi
Chair, Horizon Europe Cancer Mission Board
Katie Rizvi
founder, vice-president and acting chief executive officer, Little People
John F. Ryan
director for Public Health, Country Knowledge, Crisis Management, DG SANTE, European Commission
Jan-Willem Scheijgrond
vice president legal and IP standards, Philips
Alexey Shiryaev
President, Team-NB, The European Association Medical devices of Notified Bodies
Cristian Silviu Bușoi
member of the European Parliament (Romania, EPP)
Olga Solomon
head of unit, Medicines: policy, authorization and monitoring, DG SANTE, European Commission
Ceri Thompson
deputy head of eHealth, Wellbeing and Aging, DG CNECT, European Commission
Véronique Trillet-Lenoir
member of European Parliament, chair of the MEPs Against Cancer (MAC) Interest Group
Istvan Ujhelyi
Member of European Parliament (S&D, Hungary)
Sander van der Linden
professor of social psychology and director, Cambridge Social Decision-Making Lab, University of Cambridge
Padraic Ward
head of commercial operations, Roche
Simon White
director, supply chain quality support, Pfizer


Presenting partners

Roche is the world’s largest biotech company and a global pioneer in diagnostics. Headquartered in Basel, Switzerland it has its home at the heart of Europe and today employs over 40,000 people, has significant R&D and manufacturing capabilities, and maintains a strong commitment to ensuring new medicines and integrated solutions are available and accessible to patients in all European countries, as and when they need them.

Europe has long stood strong as a leader in healthcare. It is the home of great scientists, physicians and academic institutions, a leader in the provision of universal healthcare, and a base for many of the innovative industries that have driven advances in patient care and outcomes. It has valued the health of its citizens, and understood the importance of science and innovation to improving it. In recent years, we have seen the global healthcare innovation landscape evolve and while the EU has made considerable progress to ensure that fundamental rights of EU citizens are protected, its efforts to leverage the benefits of digitalization and EU-wide data exchange for health and healthcare trail those of the US and China.

It doesn’t have to be like this – Europe has what it will take to address this challenge and has already announced an important new commitment to a European Health Union. With a bold and optimistic Pharmaceutical Strategy that uses transformative advances in science, technology, and the delivery of healthcare, Europe can boost patient outcomes, foster greater system sustainability and further confirm its position as a destination for healthcare innovation and investment.

We believe in the future of Europe as a centre for healthcare innovation and world class patient outcomes. We are committed to doing all we can to help make it a reality. Read more here.

Social media: Twitter | LinkedIn | YouTube | Facebook

Lilly’s purpose to make life better has never been more important. Lilly is bringing the full force of our scientific and medical expertise to attack COVID-19 around the world. We’re fighting the pandemic with everything we can by discovering potential medicines to treat and prevent COVID-19.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

To learn more about Lilly, please visit us at and check out our European blog at

Social media: Twitter

In Partnership with

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

Social media: Twitter LinkedIn | YouTube | Facebook 

with the support of

The European Patients’ Forum (EPF) is the leading voice of patient organisations across Europe. We are an umbrella organisation of patient organisations across Europe and across disease-areas. Our 75 members include disease-specific patient groups active at EU level and national coalitions of patients.

Social media: Facebook | Twitter @eupatientsforum |Youtube | LinkedIn

Scroll Up